Excellent points.
After three more partnerships? Well it's going to go up probably. By many dollars. As long as they secure significantly better terms than we did with B-UP.
The question is how far do those three indications need to be advanced to get that sort of partnership? B-ABSSSI, which you didn't mention there, is our most advanced drug candidate with the most rock solid results (200+ patient phase 2b completed with outstanding results). It finished that trial five years ago and there is still no sign of partnership on it.
Quote:What is going to happen to IPIX SP when IPIX secures a lucrative IBD pill partnership with a major pharma for Colitis? How about a separate B-OM partnership? A Kevetrin trial advancement and/or partnership?
After three more partnerships? Well it's going to go up probably. By many dollars. As long as they secure significantly better terms than we did with B-UP.
The question is how far do those three indications need to be advanced to get that sort of partnership? B-ABSSSI, which you didn't mention there, is our most advanced drug candidate with the most rock solid results (200+ patient phase 2b completed with outstanding results). It finished that trial five years ago and there is still no sign of partnership on it.
1
1